Can Tramadol Help You Last Longer in Bed?

Tramadol for premature ejaculation is an off-label use of the opioid analgesic that has gained attention from clinical research over the past decade. Tramadol is primarily prescribed for moderate to severe pain, but its dual mechanism — acting on both opioid receptors and serotonin reuptake pathways — produces a side effect that delays ejaculation in many men. Multiple randomised controlled trials have demonstrated that tramadol can significantly increase intravaginal ejaculatory latency time (IELT), making it a subject of serious clinical interest for premature ejaculation (PE).

However, tramadol carries meaningful risks including dependence, seizures, and interactions with other medications. It is not approved for PE treatment in the UK, and its use for sexual performance must be carefully weighed against safer alternatives. This article reviews the clinical evidence, explains the mechanism, and sets out the risks so you can have an informed discussion with your doctor.

How Tramadol Affects Premature Ejaculation

Tramadol's effect on ejaculation comes from two distinct pharmacological actions:

• Serotonin reuptake inhibition: Tramadol weakly inhibits the reuptake of serotonin (5-HT) in the central nervous system. Higher serotonergic tone in the ejaculatory reflex pathway raises the threshold for ejaculation — the same mechanism exploited by SSRIs like dapoxetine and paroxetine when used for PE.
• Mu-opioid receptor agonism: Activation of mu-opioid receptors produces mild central nervous system depression and reduces sensitivity to physical stimulation, which can independently delay the ejaculatory reflex.

The combination of these two effects makes tramadol unusually effective for PE compared to agents that act through only one pathway. It is this dual mechanism that distinguishes tramadol from pure SSRIs and from other opioid analgesics that lack significant serotonergic activity.

What the Clinical Evidence Shows

A systematic review of eight randomised controlled trials evaluated tramadol's efficacy for premature ejaculation. The pooled results showed that tramadol consistently outperformed placebo in extending IELT, with most studies using on-demand dosing of 25–100 mg taken 1–2 hours before intercourse.

Several head-to-head studies found tramadol comparable to — and in some cases superior to — daily SSRIs for delaying ejaculation. However, these studies were generally small, short-duration, and heterogeneous in methodology. No regulatory authority has approved tramadol for PE based on this evidence, which means its use remains strictly off-label.

Dosing and Timing for PE

In the clinical trials that demonstrated efficacy, the most common dosing protocol was:

• Dose: 25–50 mg (some studies used 100 mg, but lower doses are preferred to minimise side effects)
• Timing: 1–2 hours before anticipated sexual activity (some older protocols suggested 6–8 hours, but more recent evidence supports a shorter lead time)
• Frequency: On-demand only — tramadol should not be taken daily for PE due to the risk of physical dependence

The immediate-release formulation is used for this purpose, not the extended-release version. Even at lower doses, the analgesic effects last approximately 4–6 hours, during which the ejaculation-delaying effect is also active.

Risks and Side Effects

Tramadol's risks are more serious than those of SSRIs or topical anaesthetic sprays used for PE. The key concerns are:

Dependence and addiction

Tramadol is a Schedule 3 controlled substance in the UK. Even at therapeutic doses, regular use can produce physical dependence within weeks. Withdrawal symptoms include anxiety, insomnia, sweating, and muscle pain. The risk is lower with on-demand use than daily use, but it is not zero — particularly in men who begin using tramadol more frequently than originally intended.

Seizures

Tramadol lowers the seizure threshold, especially at doses above 400 mg daily or when combined with other serotonergic drugs (including SSRIs, SNRIs, or tricyclic antidepressants). Seizures have been reported even at therapeutic doses in susceptible individuals. Men with a history of epilepsy or head injury should not use tramadol for PE.

Serotonin syndrome

Combining tramadol with other serotonergic medications can trigger serotonin syndrome — a potentially life-threatening condition characterised by agitation, hyperthermia, tremor, and muscle rigidity. This is particularly relevant because some men with PE are already prescribed SSRIs or SNRIs for depression or anxiety.

Other side effects

• Nausea and dizziness (the most common mild side effects)
• Headache
• Daytime drowsiness
• Sleep disruption — tramadol suppresses REM sleep and can cause insomnia despite its sedating properties during the day
• Constipation

Approved Alternatives for Premature Ejaculation

Before considering tramadol, men with PE should discuss approved and lower-risk treatment options with their doctor:

Dapoxetine (Priligy)

The only SSRI specifically approved for on-demand PE treatment in the UK. Taken 1–3 hours before intercourse, it increases IELT by 2–3× with a favourable safety profile. Unlike tramadol, it carries no dependence risk.

Daily low-dose SSRIs

Paroxetine, sertraline, and fluoxetine are used off-label as daily PE treatments. They require 1–2 weeks to reach full effect but produce the largest IELT increases (up to 6× baseline). Discontinuation requires a gradual taper.

Topical anaesthetic sprays

Lidocaine-prilocaine sprays (e.g., Fortacin/PSD502) reduce penile sensitivity without systemic side effects. Applied 5–15 minutes before intercourse. Available over the counter in the UK.

Behavioural techniques

The squeeze technique and stop-start method remain effective non-pharmacological options, particularly when combined with cognitive behavioural therapy. For men whose PE is linked to anxiety, addressing the psychological component of sexual performance can produce lasting improvements without medication.

The Broader Treatment Landscape

Tramadol sits within a wider spectrum of treatments for sexual dysfunction. While PE and erectile dysfunction are distinct conditions, they frequently co-occur — up to 30% of men with ED also report premature ejaculation. If you are exploring the full range of available therapies, our overview of the latest treatments for erectile dysfunction covers emerging options including shockwave therapy, penile injections, and regenerative approaches.

For men interested in how medications for sexual health compare across different conditions, clinical reference resources provide additional context on drug interactions and combination safety profiles. Always verify any medication decision with your prescribing doctor, particularly when combining treatments.

For more articles on ED medications, drug interactions, and treatment options, visit our Erectile Dysfunction resource centre.